Directed Evolution Enables Dynamic Control of Transient Intermediates for Anti-Markovnikov Wacker-Tsuji-Type Oxidation of Unactivated Alkenes

Stephan C. Hammer,Cindy Klaus,Jordi Soler,Grzegorz Kubik,Yosephine Gumulya,Yue Hui,Ella J. Watkins-Dulaney,Max-Luca Heitland,Marc Sommer,Alina Klein,Julia L. Kowal,Hartmut H. Niemann,Frances H. Arnold,Marc Garcia-Borràs
DOI: https://doi.org/10.26434/chemrxiv-2024-j0229-v2
2024-09-17
Abstract:Controlling the dynamic behavior of highly reactive fleeting intermediates is an intriguing concept to generate selectivity in competing reaction pathways. Here we report the directed evolution of a P450 enzyme for anti-Markovnikov-selective Wacker-Tsuji-type oxidation of unactivated alkenes. This reaction is a long-standing challenge in catalysis due to its unfavorable energetics and competing reactions. The evolved aMOx-A enzyme performs anti-Markovnikov oxidation of unactivated alkenes with several hundred turnovers and possesses kinetic parameters comparable to those of average natural enzymes. The biocatalyst guides an oxo-transfer process through multiple competing reactions, including bifurcating reaction pathways that originate after a rate-limiting transition state. Chemoselectivity of aMOx-A arises from controlling substrate conformations as well as dynamics of reactive intermediates. This includes accessing and controlling a fleeting carbocation intermediate that does not correspond to a minimum on the potential energy surface. Engineering of aMOx-A highlights how directed enzyme evolution optimizes unique catalytic processes that have largely eluded efficient catalysis.
Chemistry
What problem does this paper attempt to address?
The paper aims to address the issue of anti-Markovnikov selective Wacker-Tsuji type oxidation reactions for unactivated alkenes. Specifically: 1. **Background Problem**: Traditional Wacker-Tsuji reactions are typically used for the oxidation of terminal alkenes to produce ketones or aldehydes. However, there are significant challenges in directly oxidizing unactivated alkenes to aldehydes because this reaction pathway is thermodynamically unfavorable and prone to competition with other pathways (such as epoxidation). 2. **Specific Objective**: Researchers have used directed evolution techniques to modify a cytochrome P450 enzyme (named aMOx-A) to efficiently catalyze the anti-Markovnikov selective oxidation of unactivated alkenes, resulting in the corresponding aldehyde compounds. 3. **Main Challenges**: The intermediates of unactivated alkenes (such as carbocations) are very unstable and highly reactive, making it difficult to control their selectivity towards specific products. Additionally, existing chemical catalysts are inefficient in this reaction, usually limited to aromatic-substituted alkenes as substrates. In summary, the main goal of this paper is to develop a biocatalyst through enzyme engineering that can achieve high activity and high selectivity in the oxidation of unactivated alkenes. This not only helps to overcome the limitations of traditional catalytic methods but also provides new tools for organic synthesis.